Skip to main content
Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
1.180
-0.020 (-1.67%)
Nov 22, 2024, 4:00 PM EST - Market closed

Plus Therapeutics Revenue

Plus Therapeutics had revenue of $1.46M in the quarter ending September 30, 2024, with 17.42% growth. This brings the company's revenue in the last twelve months to $5.73M, up 52.63% year-over-year. In the year 2023, Plus Therapeutics had annual revenue of $4.91M with 2,093.30% growth.

Revenue (ttm)
$5.73M
Revenue Growth
+52.63%
P/S Ratio
1.20
Revenue / Employee
$286,250
Employees
20
Market Cap
6.96M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.91M4.69M2,093.30%
Dec 31, 2022224.00K--
Dec 31, 2021---
Dec 31, 2020303.00K-6.70M-95.67%
Dec 31, 20197.00M4.02M134.60%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ATI Physical Therapy 728.11M
Ontrak 11.24M
Evoke Pharma 8.62M
Syros Pharmaceuticals 386.00K
BioCardia 71.00K
Cardio Diagnostics Holdings 35.69K
Revenue Rankings

PSTV News

More News